EXONY LIMITED

Financial Health Score: A-

Explanation: Exony Limited is in excellent financial shape, resembling a healthy patient with a strong constitution and robust reserves. The company is debt-free apart from routine inter-company and tax obligations, and it continues to generate healthy profits. The only slight blemishes preventing an A+ are an overdue confirmation statement (a minor administrative compliance issue) and the fact that the company's financial circulatory system is entirely dependent on its parent company, eGain Corporation.

1. Key Vital Signs

• Net Assets (Equity Health): £3,166,830 (up from £3,055,824) The company’s "bone density" is excellent. Net assets have grown by over £111,000, indicating that the business is retaining wealth and not bleeding reserves.
• Working Capital (Circulatory Health): £3,166,830 With current assets of £3.38M easily covering current liabilities of £218k, the current ratio stands at a massive 15.5:1. The company has more than enough liquid resources to meet its immediate obligations—there is absolutely no risk of a financial heart attack here.
• Profitability (Financial Pulse): £111,006 increase in P&L Reserve Despite stating it is "no longer trading" in its active operational sense, the company still generated a profit after tax of approximately £111,000 (derived from the movement in retained earnings). The pulse is steady, driven primarily by licensing revenue or financial activities.
• Debtor Health (Arterial Flow): £3,361,059 owed by group undertakings Virtually all of the company’s assets are amounts owed by other companies within the eGain group. While this is normal for an intra-group licensing vehicle, it means the company's blood flow is entirely dependent on the health of its corporate family.

2. Diagnosis

Overall Condition: Stable and Healthy, but Functionally Dependent

Exony Limited operates as a non-trading, intellectual property, and licensing vehicle for its ultimate parent, eGain Corporation (a US entity). The financial data reveals a business with no external debt, no operational overdrafts, and a very strong balance sheet. The "symptoms" of traditional business risk—such as high leverage, cash flow shortages, or trading losses—are entirely absent.

However, there are two notable conditions to monitor: 1. Inter-company Dependency: The patient is on a corporate life-support system. £3.36M of its £3.38M in current assets are debts owed by group undertakings. If the parent company or sister companies were to face financial distress, the arteries of Exony Limited would instantly clog, turning these healthy asset numbers into potential bad debts. 2. Administrative Fever: The company has an overdue Confirmation Statement. While this doesn't impact the financials directly, it is a compliance symptom that suggests a slight neglect of statutory hygiene, which can lead to penalties or regulatory friction if left untreated.

3. Recommendations

To maintain and improve financial wellness, the following "prescriptions" are recommended:

• Cure the Compliance Fever: Immediately file the overdue Confirmation Statement with Companies House. Just as neglecting a minor cough can lead to a chest infection, ignoring statutory filings can result in financial penalties, director penalties, or even forced striking-off by the Registrar.
• Monitor the Corporate Bloodline: While the inter-company balances are currently healthy, management should ensure that eGain Corporation and related group entities remain financially solvent. Periodic "check-ups" on the parent company's creditworthiness will ensure Exony's debtor assets remain collectible.
• Optimize Cash Reserves: While cash at bank has improved from £76 to £23,326, this is still a relatively small buffer for any unexpected professional fees or administrative costs. Consider leaving a slightly larger cash cushion in the UK entity to cover localized expenses without needing to request funds from the parent.